Analysis of 2008’s shifting employment patterns
To accompany the map detailing job losses, which can be viewed here, we have picked out the details and trends from the data, uncovering the state of US pharmaceutical employment in 2008.
We present a unique concept in pharmaceutical journalism; our interactive map tracking the job losses, facility closures, expansions and openings that took place in the US in 2008. Zoom in, roam around and discover details about each individual event.
Festive cheer is scarce in the drug industry this December with B-MS, Jazz and Arpida falling into step with Pfizer and Elan and announcing job cuts.
Biotech goes cap in hand to government
Biotech bodies from around the globe have been calling on their respective governments to provide stimulus packages to compensate for the current difficulties in obtaining credit.
HHS calls for employer role in flu drug stockpiling
The US HHS says that healthcare workers and emergency service personnel should be given antivirals before this year’s flu season or any pandemic kick in and also calls for the private sector to take more of a role in stockpiling.
Helsinn’s Irish trial supplies site cleared
Helsinn’s facility in Dublin, Ireland has been cleared to package, test and store clinical trial supplies by the country’s medicines board, expanding on the US FDA approval it gained earlier this year.
Syscan files for bankruptcy
The global financial difficulties are starting to hit home in the outsourcing sector, with supply chain services company Syscan filing for bankruptcy after being unable to secure a loan.
Elan cuts staff and offices as Tysabri wavers
Irish drugmaker Elan, which recently dropped plans to sell its Elan Drug Technologies operation, has announced job cuts and the closure of offices in a bid to save cash.
EU ‘pharma package’ sees big changes for pharmacovigilance
At the heart of Europe’s new ‘pharmaceutical package’ are measures designed to improve patient protection through better safety monitoring.
Race for Commissioner hots up
The race to be the next FDA Commissioner is becoming increasingly competitive, with candidates jostling for position and interested parties attempting to influence proceedings.
Serene opens Indian IT centre
Serene has officially opened its offshore development centre in India, which will provide IT outsourcing services to support and complement its existing capabilities in the US.
MHRA OK for Almac’s Durham distribution center.
The MHRA has renewed its approval of Almac’s facility in North Carolina, bringing an end to a busy and successful four months of inspections at the clinical services group’s facilities.
Generic sales growth slows for 1st time in years
The sales growth of generic drugs slowed considerably in 2008, dipping below the customary double digits to 3.6 per cent, according to a report by IMS Health.
Kemwell forges consumer health partnership with GSK
GlaxoSmithKline has gone into partnership with Indian contract manufacturing and development services company Kemwell to set up an R&D facility aimed at developing new oral healthcare products.
Merck launches biogenerics business
Merck & Co is moving into the follow-on biologics market as it searches for new revenue streams to reduce the damage caused by generic competition.